Encinitas, CA, United States of America

Jean Marie Bruey

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Marie Bruey. Retrieved from https://idiyas.com/inventor/jean-marie-bruey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean Marie Bruey

Introduction

Jean Marie Bruey is a notable inventor based in Encinitas, California. He has made significant contributions to the field of cancer diagnosis, particularly through his innovative work on the KI-67 marker. His dedication to advancing medical technology has led to the development of a patent that aims to improve cancer detection methods.

Latest Patents

Jean Marie Bruey holds a patent for "Cancer Diagnosis Using KI-67." This patent represents a crucial step forward in the early detection of cancer, potentially leading to better patient outcomes. His work in this area highlights the importance of innovation in medical diagnostics.

Career Highlights

Bruey is currently associated with Quest Diagnostics Investments, Inc., where he continues to work on groundbreaking projects. His role at the company allows him to collaborate with other experts in the field, further enhancing his contributions to cancer research and diagnostics.

Collaborations

One of his notable coworkers is Maher Albitar, with whom he collaborates on various projects related to cancer diagnosis. Their combined expertise fosters an environment of innovation and progress in the medical field.

Conclusion

Jean Marie Bruey's work exemplifies the impact of innovation in healthcare, particularly in cancer diagnosis. His contributions through patents and collaborations are paving the way for advancements that could significantly improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…